{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:45:53Z","timestamp":1762508753636},"reference-count":21,"publisher":"Tohoku University Medical Press","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tohoku J. Exp. Med."],"published-print":{"date-parts":[[2022]]},"DOI":"10.1620\/tjem.2022.j006","type":"journal-article","created":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T22:09:23Z","timestamp":1647468563000},"page":"303-308","source":"Crossref","is-referenced-by-count":3,"title":["Anti-Mi-2 and Anti-TIF1-&lt;i&gt;\u03b3&lt;\/i&gt; Double-Positive Juvenile Dermatomyositis Treated under Diagnosis of Chronic Eczema: A Case Report"],"prefix":"10.1620","volume":"256","author":[{"given":"Shuhei","family":"Yoshida","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Fukushima Medical University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruki","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Fukushima Medical University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuya","family":"Fujita","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Fukushima Medical University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohei","family":"Yokose","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Fukushima Medical University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jumpei","family":"Temmoku","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Fukushima Medical University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Matsuoka","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Fukushima Medical University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makiko","family":"Yashiro-Furuya","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Fukushima Medical University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyuki","family":"Asano","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Fukushima Medical University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuzo","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Fukushima Medical University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiji","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Ohta Nishinouchi General Hospital Foundation"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Yago","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Fukushima Medical University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takae","family":"Yaguchi","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, Fukushima Medical University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuro","family":"Aita","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, Fukushima Medical University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Misaki","family":"Kusano","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Fukushima Medical University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiyuki","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Fukushima Medical University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Fukushima Medical University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoshi","family":"Migita","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Fukushima Medical University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"622","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Burd, C.J., Kinyamu, H.K., Miller, F.W. &amp; Archer, T.K.(2008)  UV radiation regulates Mi-2 through protein translation and stability.  <i>J. Biol. Chem<\/i>., 283, 34976-34982.","DOI":"10.1074\/jbc.M805383200"},{"key":"2","unstructured":"Feldman, B.M., Reichlin, M., Laxer, R.M., Targoff, I.N., Stein, L.D. &amp; Silverman, E.D.(1996)  Clinical significance of specific autoantibodies in juvenile dermatomyositis.  <i>J. Rheumatol<\/i>., 23, 1794-1797."},{"key":"3","doi-asserted-by":"crossref","unstructured":"Fujimoto, M., Hamaguchi, Y., Kaji, K., Matsushita, T., Ichimura, Y., Kodera, M., Ishiguro, N., Ueda-Hayakawa, I., Asano, Y., Ogawa, F., Fujikawa, K., Miyagi, T., Mabuchi, E., Hirose, K., Akimoto, N.,  et al.(2012)  Myositis-specific anti-155\/140 autoantibodies target transcription intermediary factor 1 family proteins.  <i>Arthritis Rheum<\/i>., 64, 513-522.","DOI":"10.1002\/art.33403"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Fujimoto, M., Murakami, A., Kurei, S., Okiyama, N., Kawakami, A., Mishima, M., Sato, S., Seishima, M., Suda, T., Mimori, T., Takehara, K. &amp; Kuwana, M.(2016a)  Enzyme-linked immunosorbent assays for detection of anti-transcriptional intermediary factor-1 gamma and anti-Mi-2 autoantibodies in dermatomyositis.  <i>J. Dermatol. Sci<\/i>., 84, 272-281.","DOI":"10.1016\/j.jdermsci.2016.09.013"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Fujimoto, M., Watanabe, R., Ishitsuka, Y. &amp; Okiyama, N.(2016b)  Recent advances in dermatomyositis-specific autoantibodies.  <i>Curr. Opin. Rheumatol<\/i>., 28, 636-644.","DOI":"10.1097\/BOR.0000000000000329"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Ghirardello, A., Zampieri, S., Iaccarino, L., Tarricone, E., Bendo, R., Gambari, P.F. &amp; Doria, A.(2005)  Anti-Mi-2 antibodies.  <i>Autoimmunity<\/i>, 38, 79-83.","DOI":"10.1080\/08916930400022681"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Kaji, K., Fujimoto, M., Hasegawa, M., Kondo, M., Saito, Y., Komura, K., Matsushita, T., Orito, H., Hamaguchi, Y., Yanaba, K., Itoh, M., Asano, Y., Seishima, M., Ogawa, F., Sato, S.,  et al. (2007)  Identification of a novel autoantibody reactive with 155 and 140 kDa nuclear proteins in patients with dermatomyositis: an association with malignancy.  <i>Rheumatology (Oxford)<\/i>, 46, 25-28.","DOI":"10.1093\/rheumatology\/kel161"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Kotobuki, Y., Tonomura, K. &amp; Fujimoto, M.(2021)  Transcriptional intermediary factor 1 (TIF1)  and anti-TIF1gamma antibody-positive dermatomyositis.  <i>Immunol. Med<\/i>., 44, 23-29.","DOI":"10.1080\/25785826.2020.1791402"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Liang, L., Zhang, Y.M., Chen, H., Ye, L.F., Li, S.S., Lu, X., Wang, G.C. &amp; Peng, Q.L.(2020)  Anti-Mi-2 antibodies characterize a distinct clinical subset of dermatomyositis with favourable prognosis.  <i>Eur. J. Dermatol<\/i>., 30, 2.","DOI":"10.1684\/ejd.2020.3750"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Mammen, A.L., Casciola-Rosen, L.A., Hall, J.C., Christopher-Stine, L., Corse, A.M. &amp; Rosen, A.(2009)  Expression of the dermatomyositis autoantigen Mi-2 in regenerating muscle.  <i>Arthritis Rheum<\/i>., 60, 3784-3793.","DOI":"10.1002\/art.24977"},{"key":"11","doi-asserted-by":"crossref","unstructured":"McAvera, R.M. &amp; Crawford, L.J.(2020)  TIF1 proteins in genome stability and cancer.  <i>Cancers (Basel)<\/i>, 12, 2094.","DOI":"10.3390\/cancers12082094"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Morris, P. &amp; Dare, J.(2010)  Juvenile dermatomyositis as a paraneoplastic phenomenon: an update.  <i>J. Pediatr. Hematol. Oncol<\/i>., 32, 189-191.","DOI":"10.1097\/MPH.0b013e3181bf29a2"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Ogawa-Momohara, M., Muro, Y. &amp; Akiyama, M.(2019)  Anti-Mi-2 antibody titers and cutaneous manifestations in dermatomyositis.  <i>J. Cutan. Immunol. Allergy<\/i>, 2, 49-52.","DOI":"10.1002\/cia2.12048"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Pagnini, I., Vitale, A., Selmi, C., Cimaz, R. &amp; Cantarini, L.(2017)  Idiopathic inflammatory myopathies: an update on classification and treatment with special focus on juvenile forms.  <i>Clin. Rev. Allergy Immunol<\/i>., 52, 34-44.","DOI":"10.1007\/s12016-015-8512-9"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Rider, L.G. &amp; Nistala, K.(2016)  The juvenile idiopathic inflammatory myopathies: pathogenesis, clinical and autoantibody phenotypes, and outcomes.  <i>J. Intern. Med<\/i>., 280, 24-38.","DOI":"10.1111\/joim.12444"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Rider, L.G., Shah, M., Mamyrova, G., Huber, A.M., Rice, M.M.,  Targoff, I.N. &amp; Miller, F.W.; Childhood Myositis Heterogeneity Collaborative Study Group (2013)  The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies.  <i>Medicine (Baltimore)<\/i>, 92, 223-243.","DOI":"10.1097\/MD.0b013e31829d08f9"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Shimizu, K., Kobayashi, T., Kano, M., Hamaguchi, Y., Takehara, K. &amp; Matsushita, T.(2020)  Anti-transcriptional intermediary factor 1-gamma antibody as a biomarker in patients with dermatomyositis.  <i>J. Dermatol<\/i>., 47, 64-68.","DOI":"10.1111\/1346-8138.15128"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Stuhlmuller, B., Schneider, U., Gonzalez-Gonzalez, J.B. &amp; Feist, E.(2019)  Disease specific autoantibodies in idiopathic inflammatory myopathies.  <i>Front. Neurol<\/i>., 10, 438.","DOI":"10.3389\/fneur.2019.00438"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Takezaki, D., Onishi, S., Hamaguchi, Y., Fujimoto, M., Kohzan, H. &amp; Hamada, T.(2020)  Myositis-specific autoantibodies reacting to both Tif1gamma and Mi-2 in a patient with juvenile dermatomyositis.  <i>Acta Derm. Venereol<\/i>., 100, adv00238.","DOI":"10.2340\/00015555-3594"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Tansley, S.L., McHugh, N.J. &amp; Wedderburn, L.R.(2013)  Adult and juvenile dermatomyositis: are the distinct clinical features explained by our current understanding of serological subgroups and pathogenic mechanisms?  <i>Arthritis Res. Ther.<\/i>, 15, 211.","DOI":"10.1186\/ar4198"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Tuen, V.C., Zingula, S.N., Moir, C., Reed, A.M., Matsumoto, J.M. &amp; Woodrum, D.A.(2013)  MRI guided wire localization muscle biopsy in a child with juvenile dermatomyositis.  <i>Pediatr. Rheumatol. Online J<\/i>., 11, 15.","DOI":"10.1186\/1546-0096-11-15"}],"container-title":["The Tohoku Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/256\/4\/256_2022.J006\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,23]],"date-time":"2022-04-23T04:25:54Z","timestamp":1650687954000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/256\/4\/256_2022.J006\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1620\/tjem.2022.j006","relation":{},"ISSN":["0040-8727","1349-3329"],"issn-type":[{"value":"0040-8727","type":"print"},{"value":"1349-3329","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]},"article-number":"2022.J006"}}